Learning from combination HIV prevention programmes to face COVID-19 emerging pandemic

Imagem de Miniatura
Arquivos
art_PALACIOS_Learning_from_combination_HIV_prevention_programmes_to_face_2020.PDF (859.26 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2020
DOI
SciELO
Scopus
Web of Science
Título da Revista
ISSN da Revista
Título do Volume
Editora
CORPORACION EDITORA MEDICA VALLE
Autores
PALACIOS, Ricardo
Citação
COLOMBIA MEDICA, v.51, n.2, article ID e-4276, 13p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Before a vaccine against SARS-CoV-2 became available, several measures to control COVID-19 pandemic are necessary. Analogously, in the absence of an available vaccine, Combination HIV Prevention Programmes have consolidated a large experience of biomedical, behavioral and structural interventions suitable for several epidemiological settings. Adaptation of such experiences can organize mid-term and long-term responses to face COVID-19.
Antes de que una vacuna contra el SARS-CoV-2 esté disponible, son necesarias varias medidas para controlar la pandemia de COVID-19. Análogamente, en ausencia de una vacuna disponible, los Programas Combinados de Prevención del VIH han consolidado una gran experiencia de intervenciones biomédicas, conductuales y estructurales adecuadas para varios entornos epidemiológicos. La adaptación de tales experiencias puede organizar respuestas a medio y largo plazo para enfrentar COVID-19.
Palavras-chave
COVID-19, Coronavirus, Acquired Immunodeficiency Syndrome, Pandemics, severe acute respiratory syndrome coronavirus 2, Coronavirus Infections, Severe Acute Respiratory Syndrome, Immunization, Vaccination, Vaccines, United Nations, Government, Síndrome de inmunodeficiencia adquirida, Pandemias, síndrome respiratorio agudo severo, Infecciones por coronavirus, Síndrome respiratorio agudo severo, Inmunización, Vacunación, Vacunas, Naciones Unidas, Gobierno
URI
https://observatorio.fm.usp.br/handle/OPI/37938
Referências
  1. Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2
  2. Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
  3. [Anonymous], 2018, JAIDS-J ACQ IMM DEF, V79, P38, DOI [10.1097/QAI.0000000000001726, DOI 10.1097/QAI.0000000000001726]
  4. [Anonymous], 2014, UNP H 90 90 90 AMB T
  5. Ayres José Ricardo Carvalho Mesquita, 2002, Interface (Botucatu), V6, P11, DOI 10.1590/S1414-32832002000200002
  6. Basthi A, 2016, MYTH VS REALITY EVAL
  7. Beanland RL, 2015, CLIN INFECT DIS, V60, pS191, DOI 10.1093/cid/civ070
  8. Bryant J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13140
  9. CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019
  10. Cao WCC, 2007, NEW ENGL J MED, V357, P1162, DOI 10.1056/NEJMc070348
  11. Carlos JA, 2010, AIDS EDUC PREV, V22, P430, DOI 10.1521/aeap.2010.22.5.430
  12. Centers for Disease Control and Prevention, 2020, REC REG US CLOTH FAC
  13. Centers for Disease Control and Prevention, 2020, INT REC US HOUS SUSP
  14. Cheng H, 2020, J MED VIROL, V92, P726, DOI 10.1002/jmv.25785
  15. Choko AT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208191
  16. Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2
  17. Cohen J, 2020, CORONAVIRUS RES COMM, DOI 10.1126/SCIENCE.ABB7733
  18. Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI 10.1056/NEJMoa1105243
  19. di Mauro Beatrice Weder, 2020, MITIGATING COVID EC
  20. Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828
  21. Donovan B, 2000, SEX TRANSM INFECT, V76, P88, DOI 10.1136/sti.76.2.88
  22. Dudley JP, 2020, CLIN INFECT DIS, DOI [10.1101/2020.03.24.20042598, DOI 10.1101/2020.03.24.20042598]
  23. Eichenberger R, 2020, CENT RES EC MANAG AR
  24. Eisinger RW, 2019, JAMA-J AM MED ASSOC, V321, P451, DOI 10.1001/jama.2018.21167
  25. Flowers P, 2001, HEALTH-LONDON, V5, P50, DOI 10.1177/136345930100500103
  26. Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145
  27. Ford N, 2015, CLIN INFECT DIS, V60, pS182, DOI 10.1093/cid/civ093
  28. Gardner W, 2020, J AGING SOC POLICY, V32, P310, DOI 10.1080/08959420.2020.1750543
  29. Gorbach PM, 2009, SEX TRANSM DIS, V36, P193, DOI 10.1097/OLQ.0b013e3181901ccf
  30. Gourinchas P.-O., 2020, MITIGATING COVID EC, P31
  31. Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205
  32. Gray RH, 2008, LANCET, V371, P2064, DOI 10.1016/S0140-6736(08)60896-X
  33. Harcourt C, 2010, AUST NZ J PUBL HEAL, V34, P482, DOI 10.1111/j.1753-6405.2010.00594.x
  34. Hayes R, 2010, AIDS, V24, pS15, DOI 10.1097/01.aids.0000390704.35642.47
  35. Houser KV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006565
  36. Kaplan JE, 2015, CLIN INFECT DIS, V60, pS196, DOI 10.1093/cid/civ087
  37. Khamsi R, 2020, NATURE
  38. Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1
  39. Laar A, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0129-z
  40. Li RY, 2020, SCIENCE, V368, P489, DOI 10.1126/science.abb3221
  41. Lloyd-Sherlock P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1052
  42. Lohiniva AL, 2020, EUROSURVEILLANCE, V25, P17, DOI 10.2807/1560-7917.ES.2020.25.13.2000317
  43. Madjid M, 2020, JAMA CARDIOL, DOI [10.1001/jamacardio.2020, DOI 10.1001/JAMACARDIO.2020]
  44. Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557
  45. Mandavilli A, 2003, NAT MED, V9, P487, DOI 10.1038/nm0503-487
  46. Nelson KM, 2019, J ADOLESCENT HEALTH, V64, P36, DOI 10.1016/j.jadohealth.2018.07.015
  47. Nilo F., 2015, B ABTA, V60, P8
  48. PAHO
  49. WHO
  50. UNAIDS, 2017, HIV PREV SPOTL AN PE, P88
  51. Parsons JT, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000167348.15750.9a
  52. Payne DC, 2016, EMERG INFECT DIS, V22, P1824, DOI 10.3201/eid2210.160706
  53. Perrusi A, 2012, REV CIENCIAS SOCIAIS, V2, P179
  54. Pettifor A, 2016, LANCET GLOB HEALTH, V4, pE978, DOI [10.1016/s2214-109x(16)30253-4, 10.1016/S2214-109X(16)30253-4]
  55. Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6
  56. Pueyo T, 2020, CORONAVIRUS HAMMER D
  57. Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282
  58. Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5
  59. Thienkrua W, 2016, J HOMOSEXUAL, V63, P507, DOI 10.1080/00918369.2015.1088319
  60. UNAIDS, 2010, COMB HIV PREV TAIL C
  61. UNAIDS, 2010, COMB ION HIV PREV TA
  62. van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI 10.1056/NEJMc2004973
  63. Vekemans J, 2020, LANCET HIV, V7, pE141, DOI 10.1016/S2352-3018(19)30294-2
  64. Vermund SH, 2017, JAIDS-J ACQ IMM DEF, V74, pS1, DOI 10.1097/QAI.0000000000001211
  65. Vermund SH, 2014, JAIDS-J ACQ IMM DEF, V66, pS237, DOI 10.1097/QAI.0000000000000244
  66. Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
  67. Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
  68. World Health Organization, 2014, CONS GUID HIV PREV D, P184
  69. York Ashley, 2019, Nat Rev Microbiol, V17, P399, DOI 10.1038/s41579-019-0215-4
  70. Zhu Yuner, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.68

Coleções
Artigos e Materiais de Revistas Científicas - LIM/38
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/05